NCT00965978已完成1 期
A Study to Evaluate Food Effect on Pharmacokinetics Parameters After Administration of ONO-5920/YM529 Intermittent Formulation
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 48
- 主要终点
- Pharmacokinetic parameter of ONO-5920/YM529
研究概览
简要总结
The aim of the study is to evaluate the effects of food intake on the plasma concentration profile of YNO-5920/YM529 in post menopausal women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 81 Years(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Post menopausal women (at least 2 years after menopause)
- •Body weight: more than 40.0 Kg and less than 70.0 Kg
- •BMI: more than 17.6 and less than 30.0
排除标准
- •Receives investigational drug within 120 day before the study
- •Blood donation before the study
- •With abnormal laboratory values
研究组 & 干预措施
Low dose group
Experimental
Receives low dose of ONO-5920/YM529 with and without food
干预措施: ONO-5920 / YM529 (Drug)
High dose group
Experimental
Receives high dose of ONO-5920/YM529 with and without food
干预措施: ONO-5920 / YM529 (Drug)
结局指标
主要结局
Pharmacokinetic parameter of ONO-5920/YM529
时间窗: For 48 hours
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
The Effect of Food on the Pharmacokinetic Characteristics of CKD-501HealthyNCT01071720Chong Kun Dang Pharmaceutical24
已完成
1 期
A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941HealthyPharmacokinetics of ASP1941NCT01674777Astellas Pharma Inc30
已完成
1 期
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerNon Small Cell Lung Cancer (NSCLC)Estrogen Receptor Breast CancerBreast CancerLung CancerNCT01594398Syndax Pharmaceuticals14
尚未招募
1 期
A Study Evaluating Food Effect on Pharmacokinetics of HS-10518EndometriosisNCT06554548Jiangsu Hansoh Pharmaceutical Co., Ltd.8
已完成
1 期
A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington DiseaseHuntington's DiseaseNCT01485965Siena Biotech S.p.A.26
